By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Qiagen will distribute a multiplex respiratory pathogen test manufactured by Celera, under an agreement announced today by the firms.

The molecular diagnostic test is the next-generation version of Qiagen's ResPlex II assay for detecting respiratory pathogens. The assay detects 19 different pathogens associated with respiratory infections and is designed for use on the LiquiChip 100 and 200 instrument platforms, which are based on Luminex's technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.